AFP
GWPH

Ausdal Financial Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ausdal Financial Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-193
Closed -$13K – 1122
2015
Q4 		$13K Buy
+193
New +$15.7K 0.01% 846

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ausdal Financial Partners's GWPH Position: Q1 2016 in Review

Ausdal Financial Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2016, closing a stake of 193 shares — an estimated $13K sold.

Ausdal Financial Partners first reported a position in GWPH in Q4 2015 and held it in 1 quarter. The position peaked at $13K in Q4 2015. 108 funds tracked by Wall St. Rank hold GWPH as of Q1 2016.

  • Ausdal Financial Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2016 after selling out during the quarter.
  • Ausdal Financial Partners sold 193 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2016, an estimated $13K.
  • Ausdal Financial Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 1 quarter.
  • Ausdal Financial Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $13K in Q4 2015.
  • 108 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2016.

Based on Ausdal Financial Partners's 13F filing for Q1 2016, filed 5 May 2016.